Skip to main content

Fidelity — Portfolio, Page 4

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

257
Companies
$23.8B
Total invested
$138.5M
Avg. check
47
Industries
Biotechnology 9Health Care 6Medical 6Therapeutics 6Artificial Intelligence (AI) 5Life Science 4+41 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 7396 of 257
ZILO
September 2025

ZILO's mission is to innovate and deliver transformative technology that enables organisations to operate more efficiently.

Asset Management · London$27.0M Series A
Treeline Biosciences
September 2025

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

Biotechnology · Watertown$200.0M Series A
Galvanize Therapeutics
September 2025

Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.

Health Care · San Carlos$100.0M Series C
Wugen
August 2025

Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

Biotechnology · St Louis$115.0M Series C
Conformal Medical
August 2025

Conformal Medical is an early stage medical device company developing devices to prevent stroke in patients.

Health Care · Nashua$31.8M Series D
Farmers Business Network
July 2025

Farmers Business Network is a digital marketplace that helps farmers buy inputs, access financing, and join marketing programs.

Agriculture · San Carlos$50.0M Venture - Series Unknown
GupShup
July 2025

Gupshup offers a platform for businesses to build AI-powered messaging, chatbots, and customer engagement.

Artificial Intelligence (AI) · San Francisco$60.0M Venture - Series Unknown
Retym
March 2025

Retym is a semiconductor startup that builds semiconductor technology to transform the data center and telecommunications industries.

Manufacturing · Cupertino$75.0M Series D
73 Strings
February 2025

73 Strings provides financial advisory services using artificial intelligence and technology solutions.

Advice · Paris$55.0M Series B
Frore Systems
May 2024

Frore Systems is a developer of thermal technology for consumer devices.

Consumer Electronics · San Jose$80.0M Series C
GO
October 2023

GO is a developer of both software and hardware in the field of transportation and mobility based on a taxi system.

Automotive · TokyoSeries D
Evozyne
September 2023

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Artificial Intelligence (AI) · Chicago$81.0M Series B
GenePlanet
July 2023

GenePlanet is a European company active in the field of biotechnology, specializing in genetic testing and research.

Biotechnology · Ljubljana$22.4M Series B
Moloco
June 2023

Moloco offers programmatic advertising solutions to help optimize the client's acquisition, retention, and monetization campaigns.

Advertising · Redwood City$24.2M Series D
Gridwealth
April 2023

Gridwealth lowers GHG emissions while generating long-term cash for customer buildings.

Manufacturing · Boston$30.0M Venture - Series Unknown
Moonfare
February 2023

Moonfare is a digital platform that provides HNWI, family offices, banks and their advisors access to top-tier private markets investments.

Asset Management · Berlin$15.0M Series C
Monte Rosa Therapeutics
January 2026

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Biotechnology · Basel$300.0M Post-IPO Equity
Century Therapeutics
January 2026

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Biotechnology · Philadelphia$135.0M Post-IPO Equity
CareMax
January 2022

CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors.

Health Care · Miami$1.0M Post-IPO Equity
Lyte AI
January 2026

Lyte AI offers a low-code fintech platform that enables companies to build, launch, and scale digital banking and compliance tools.

Artificial Intelligence (AI) · Mountain View$107.0M Venture - Series Unknown
Asimov
January 2023

Asimov employs artificial intelligence to develop tools for the design and manufacture of next-generation therapeutics.

Artificial Intelligence (AI) · Boston$175.0M Series B
SalioGen Therapeutics
January 2022

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.

Biotechnology · Burlington$115.0M Series B
Voyager Therapeutics
January 2024

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Biotechnology · Cambridge$100.0M Post-IPO Equity
ESS
January 2026

ESS is an energy storage company that designs and produces iron flow batteries for commercial and utility-scale energy storage applications.

Electronics · Wilsonville$15.0M Post-IPO Equity

Where Fidelity invests

Biotechnology9
Health Care6
Medical6
Therapeutics6
Artificial Intelligence (AI)5
Life Science4

About Fidelity's portfolio

How many companies has Fidelity invested in?

Fidelity has invested in 257 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Fidelity invest in?

Fidelity's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Artificial Intelligence (AI). The firm invests across 47 different industry categories.

What is Fidelity's largest investment?

Among tracked funding rounds, Monte Rosa Therapeutics received $300.0M in a Post-IPO Equity round. Fidelity's total known invested capital is $23.8B.

What is the average investment size for Fidelity?

Fidelity's average investment size is $138.5M across its portfolio of 257 companies.

What are Fidelity's most recent investments?

Recent Fidelity portfolio additions include ZILO, Treeline Biosciences, Galvanize Therapeutics, Wugen, Conformal Medical. These companies were founded in 2020 or later.

Reach the founders behind these 257 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →